Lourdes Hontecillas‐Prieto

Author

Also Known As

L Hontecillas-Prieto, L. Hontecillas-Prieto, Lourdes Hontecillas-Prieto, Lourdes Hontecillas‐Prieto, Lourdes Hontecillas‑Prieto

Publications

Citations

H-Index

Concepts

All Affiliations

Universidad de Sevilla Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío Hospital Sant Joan de Déu Barcelona Institut d'Investigació Biomédica de Bellvitge

About

Lourdes Hontecillas‐Prieto is an author at Universidad de Sevilla specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	362
2	Cell Biology	9	9	352
3	Health Sciences	1	1	23
4	Social Sciences	1	1	109
5	Cognitive Science	1	1	109

Lourdes Hontecillas‐Prieto

Publications

687

Citations

H-Index

Page 1

	Year	Citations
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases Juan Ignacio Díaz‐Hernandéz, Rosa Gómez‐Villafuertes, Míriam León‐Otegui, Neurobiology of Aging Neurodegenerative DiseasesAlzheimer's DiseaseMedicineDegenerative PathologyProtein Misfolding	2011	192
The hippocampal dentate gyrus is essential for generating contextual memories of fear and drug-induced reward Vicente Hernández‐Rabaza, Lourdes Hontecillas‐Prieto, Clara Velázquez-Sánchez, Neurobiology of Learning and Memory Drug-induced RewardCognitive ScienceNeuropsychologyNeurobiological MechanismNeurobiological Factor	2008	109
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma Sílvia García-Monclús, Roser López‐Alemany, Olga Almacellas‐Rabaiget, International Journal of Cancer	2018	59
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach Andrés Castellanos‐Martín, Sonia Castillo‐Lluva, María del Mar Sáez‐Freire, Genome Biology	2015	30
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1 Juan Huertas-Martínez, Franck Court, Santiago Rello‐Varona, Cancer Letters Ewing SarcomaMedicineDna MethylationPathologyCancer Genomics	2016	30
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis Sara Sánchez-Molina, Elisabet Figuerola-Bou, Enrique Blanco, Science Advances	2020	30
The biological age linked to oxidative stress modifies breast cancer aggressiveness María del Mar Sáez‐Freire, Adrián Blanco‐Gómez, Sonia Castillo‐Lluva, Free Radical Biology and Medicine Breast OncologyCancer AggressivenessLongevityBiological AgePathology	2018	29
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma Daniel J. García-Domínguez, Lourdes Hontecillas‐Prieto, Pablo Rodríguez‐Núñez, Oncotarget	2018	29
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer Daniel J. García-Domínguez, Soledad López, Gonzalo Álba, International Journal of Molecular Sciences ImmunologyImmune Cell TherapyImmune SystemImmunotherapyTumor Biology	2024	23
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma Daniel J. García-Domínguez, Nabil Hajji, Sara Sánchez-Molina, Oncogene	2021	21

Page 1